Themis Medicare Share Price

Themis Medicare Share Price

NSE: THEMISMED
|
Pharmaceuticals
|
S Cap
₹ 120.10
-₹8.15 (-6.35%)
1D
Last updated 15 Sep, 2026, 15:29 IST

Themis Medicare Share Price Today

As of 16 Sep 2026, Themis Medicare share price is ₹120.10. The stock opened at ₹129.85, compared to its previous close of ₹128.25. During today's trading session, Themis Medicare share price moved in the range of ₹120.10 to ₹129.85, with an average price of ₹124.97 for the day. Looking at its last 52-week, the stock has touched a low of ₹64.95 and a high of ₹148.00. On the performance front, Themis Medicare share price has increased by 55.82% over the last six months and is down 7.59% on a year-on-year basis.

₹120.10
6.35% down today
₹129.85
1D LOW
1D HIGH

Themis Medicare Returns Calculator

Circuit
L
H
₹102.60
₹153.90
52-week
L
H
₹64.95
₹148.00

About Themis Medicare

Themis Medicare Share Price
ISIN
INE083B01024
Sector Market Cap
₹ 1,178.42 Cr

Themis Medicare Limited is a research-based pharmaceutical company, which is engaged in the manufacturing of pharmaceutical products, especially in formulation and active pharmaceutical ingredients (API) activity. The Company operates through one segment: Pharmaceuticals. The Company manufactures therapeutic pharma products, differential healthcare products, and APIs based in India. The Company specializes in manufacturing a range of products for application areas like pain management, critical care and anti-infectives. Its analgesic and anti-inflammatory products include Aquadol Tpm Gel, Etojet 90 10'S, Etojet 120 10'S, Etojet Mr Tablets 10'S, Etojet XP Gel, Themidol-P Tab 10's, Dhoom, Aquadol inj, Dyloaqua inj, Joydol -P, Joydol -SP, Joydol -TH, and Nimujet Gel. Its Analgesics products include Anemol, Tazowin, Themidol, Themidol. Its Anesthesia products include Bupicaine 0.25%, Ketmin 2 Vial, Ketmin 5, Ropicaine 2, Themicaine 2%, and more.

Themis Medicare Financial Highlights

  • Revenue: Themis Medicare reported revenue of ₹351.60 crore in FY26 vs ₹410.18 crore in FY25. It showed a decrease of 14.28% on a yearly basis.
  • Operating Profit: Themis Medicare reported an operating profit of ₹1.93 crore in FY26 vs ₹39.67 crore in FY25. It showed a decrease of 95.13% on a year-on-year basis.
  • Net Profit: Themis Medicare reported a net profit of ₹1.14 crore in FY26 vs ₹29.83 crore in FY25. It showed a decrease of 96.18% on a yearly basis.

Themis Medicare Quarterly Result Highlights

  • Themis Medicare reported revenue of ₹87.95 crore in Jun 2026, compared with ₹80.20 crore in Mar 2026, representing an increase of 9.66% on a quarter-on-quarter (QoQ) basis.
  • Themis Medicare reported an operating profit of ₹38.60 crore in Jun 2026, compared with ₹9.06 crore in Mar 2026, representing an increase of 326.05% on a quarter-on-quarter (QoQ) basis.
  • Themis Medicare reported a profit of ₹24.61 crore in Jun 2026, compared with ₹8.89 crore in Mar 2026, reflecting an increase of 176.83% on a QoQ basis.
  • The earnings per share (EPS) of Themis Medicare stood at ₹3.24 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
67.11%
FII
0.01%
Other DII
0.01%
Retail and other
32.87%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20250.06%
Dec 20250.05%
Mar 20260.11%
Jun 20260.01%
Mkt Cap Cr
1,178.42
P/E
29.48
P/B
3.22
ROE
0.42%
D/E
0.33
ROCE
2.70%
Div. Yield
0.39%
EPS(TTM)
-1.54
Turnover
0.66
EV/EBITDA
16.72
Net Margin
0.00%
Op. Margin
0.00%
ROA
6.68%
Quick Ratio
0.00
Curr. Ratio
3.47
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Themis Medicare outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Themis Medicare appears overvalued compared to its peers
Step 3 of 5
Earnings
Neutral
Themis Medicare earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,41,958.0036.485.2913.74%0.6117.33%93.240.87%0.4810.90
Divis Laboratories2,47,576.0084.6414.7715.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,89,233.0087.7722.5025.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,11,671.0024.324.1218.59%0.3117.35%237.300.09%0.3335.38
Cipla1,10,273.0032.863.2011.27%0.0014.95%423.360.95%0.4543.52
Laurus Labs1,06,460.0097.6420.0916.77%0.4016.14%97.200.10%0.6713.72
Dr. Reddy's Laboratories96,906.4030.442.5511.07%0.1812.54%377.950.69%0.4138.68
Aurobindo Pharma96,401.7025.982.549.25%0.1911.76%394.820.24%0.3841.58
Lupin95,842.9017.274.2723.76%0.0424.88%659.000.86%0.57129.18
Mankind Pharma94,050.4045.495.7711.74%0.3413.13%396.980.04%0.4449.37

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Themis Medicare Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹405.51₹381.76₹354.32₹394.61
Other Income₹4.67₹4.76₹11.50₹6.54
Total Revenue₹410.18₹386.52₹365.83₹401.16
Total Expenses₹376.43₹351.88₹306.93₹317.23
Profit Before Tax₹39.67₹53.44₹72.51₹95.26
Tax₹9.84₹9.92₹15.61₹22.38
Profit After Tax₹29.83₹43.52₹56.90₹72.88
EPS - Basic₹3.24₹4.73₹6.18₹79.22
EPS - Diluted₹3.24₹4.72₹6.17₹79.07

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹39.67₹53.44₹72.51₹95.26
Income before WC changes₹50.57₹51.97₹72.54₹95.02
Change in Assets-₹14.31-₹31.83-₹56.66-₹28.96
Change in Liabilities₹9.20₹10.91₹16.36-₹13.59
Change in WC-₹5.11-₹20.92-₹40.30-₹42.55
Cash flow from Operations₹34.71₹22.09₹16.09₹34.39
Cash flow from Investing-₹12.17-₹15.95-₹23.96-₹15.59
Cash flow from Financing-₹25.90-₹8.77₹0.14-₹17.55
Total Cash Flow-₹3.36-₹2.62-₹7.73₹1.26
Cash (Start of the year)₹9.92₹12.55₹20.28₹19.02
Cash (End of the year)₹6.56₹9.92₹12.55₹20.28

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹284.17₹273.25₹249.43₹213.62
Current Assets₹303.87₹293.17₹264.53₹214.16
Total Assets₹588.03₹566.42₹513.96₹427.78
Current Liabilities₹156.12₹154.58₹139.13₹109.52
Net Current Asset₹147.74₹138.58₹125.40₹104.64
Non-Current Liabilities₹29.31₹34.17₹35.39₹30.77
Equity Capital₹402.60₹377.67₹339.44₹287.49
Total Equity & Liabilities₹588.03₹566.42₹513.96₹427.78

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹342.24₹405.51₹381.76₹354.32
Other Income₹9.36₹4.67₹4.76₹11.50
Total Revenue₹351.60₹410.18₹386.52₹365.83
Total Expenses₹362.84₹376.42₹351.85₹306.92
Profit Before Tax-₹13.40₹33.76₹34.67₹58.91
Tax₹0.78₹9.84₹9.92₹15.61
Profit After Tax-₹14.19₹23.92₹24.75₹43.29
EPS - Basic-₹1.54₹2.60₹2.69₹4.70
EPS - Diluted-₹1.54₹2.59₹2.68₹4.70

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax-₹13.40₹33.76₹34.67₹58.91
Income before WC changes₹3.90₹50.58₹51.99₹72.57
Change in Assets-₹1.89-₹14.32-₹31.89-₹56.68
Change in Liabilities₹1.12₹9.20₹10.91₹16.34
Change in WC-₹0.77-₹5.12-₹20.99-₹40.34
Cash flow from Operations-₹3.27₹34.71₹22.04₹16.07
Cash flow from Investing-₹2.54-₹12.17-₹15.96-₹23.96
Cash flow from Financing₹3.79-₹25.90-₹8.77₹0.14
Total Cash Flow-₹2.02-₹3.36-₹2.68-₹7.75
Cash (Start of the year)₹6.47₹9.83₹12.51₹20.27
Cash (End of the year)₹4.45₹6.47₹9.83₹12.51

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹195.22₹200.50₹195.52₹190.49
Current Assets₹304.99₹305.15₹294.44₹265.80
Total Assets₹500.21₹505.65₹489.97₹456.29
Current Liabilities₹166.10₹156.06₹152.92₹139.07
Net Current Asset₹138.90₹149.09₹141.52₹126.72
Non-Current Liabilities₹33.17₹29.31₹35.77₹35.39
Equity Capital₹300.95₹320.29₹301.28₹281.83
Total Equity & Liabilities₹500.21₹505.65₹489.97₹456.29
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
121.57
67
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 67
Buy orders: 0%
Sell orders: 100%
Bearish
1
Neutral
6
Bullish
1
Neutral
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
59.57
Neutral
ATR (14)
7.21
Neutral
STOCH(9,6)
42.37
Neutral
STOCH RSI (14)
30.65
Neutral
ADX(9)
42.29
Bearish
UO(9)
44.58
Neutral
ROC(12)
1.58
Bullish
WillR(14)
-52.67
Neutral
Period
Simple value
Exponential vaue
5D
131.65
129.74
10D
127.6
127.55
20D
120.9
123.13
50D
115.1
116.34
100D
109.39
110.04
Volume trend — traded volume by day
15 Sep1L
11 Sep1L
10 Sep0L
9 Sep3L
Average1L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
Themis Medicare Share Price
Themis Medicare
Pharmaceuticals
Add Stock
Add Another

Themis Medicare Share Price FAQs

Themis Medicare share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837